Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 95-100

  Cadilla, Adriana ^a   David, Michael Z ^a   Daum, Robert S ^a   Boyle Vavra, Susan ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; GENOTYPE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM SAMPLE; UNITED STATES;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHICAGO; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUPIROCIN; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 78650914842     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00759-10     Document Type: Article

References (37)

1. Association for Professionals in Infection Control and Epidemiology. 2010. MRSA laws and pending legislation. APIC, Washington, DC. http://www.apic.org/downloads/legislation/MRSA-map.gif.
2. Aubry-Damon, H., C. J. Soussy, and P. Courvalin. 1998. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42:2590-2594.
3. Babu, T., V. Rekasius, J. P. Parada, P. Schreckenberger, and M. Challapalli. 2009. Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center. J. Clin. Microbiol. 47:2279-2280.
4. Bischoff, W. E., M. L. Wallis, K. B. Tucker, B. A. Reboussin, and R. J. Sherertz. 2004. Staphylococcus aureus nasal carriage in a student community: prevalence, clonal relationships, and risk factors. Infect. Control Hosp. Epidemiol. 25:485-491.
5. Bowler, W. A., J. Bresnahan, A. Bradfish, and C. Fernandez. 2010. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting. Infect. Control Hosp. Epidemiol. 31:269-275.
6. Boyle-Vavra, S., and R. S. Daum. 2007. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab. Invest. 87:3-9.
7. Boyle-Vavra, S., B. Ereshefsky, C. C. Wang, and R. S. Daum. 2005. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J. Clin. Microbiol. 43:4719-4730.
8. Cadilla, A., R. S. Daum, and S. Boyle-Vavra. 2009. Mupirocin resistance associated with multi-drug resistant MRSA. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-140.
9. David, M. Z., D. Glikman, S. E. Crawford, J. Peng, K. J. King, M. A. Hostetler, S. Boyle-Vavra, and R. S. Daum. 2008. What is community-associated methicillin-resistant Staphylococcus aureus? J. Infect. Dis. 197:1235-1243.
10. Deshpande, L. M., A. M. Fix, M. A. Pfaller, and R. N. Jones. 2002. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn. Microbiol. Infect. Dis. 42:283-290.
11. Diep, B. A., H. F. Chambers, C. J. Graber, J. D. Szumowski, L. G. Miller, L. L. Han, J. H. Chen, F. Lin, J. Lin, T. H. Phan, H. A. Carleton, L. K. McDougal, F. C. Tenover, D. E. Cohen, K. H. Mayer, G. F. Sensabaugh, and F. Perdreau-Remington. 2008. Emergence of multidrug-resistant, commu- nity-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann. Intern. Med. 148:249-257.
12. Eltringham, I. 1997. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J. Hosp. Infect. 35:1-8.
13. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
14. Farmer, T. H., J. Gilbart, and S. W. Elson. 1992. Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus. J. Antimicrob. Chemother. 30:587-596.
15. Fridkin, S. K., J. C. Hageman, M. Morrison, L. T. Sanza, K. Como-Sabetti, J. A. Jernigan, K. Harriman, L. H. Harrison, R. Lynfield, and M. M. Farley. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
16. GlaxoSmithKline. 2009. Bactroban nasal prescribing information. Glaxo-SmithKline, Brentford, United Kingdom. http://us.gsk.com/products/assets/ us-bactroban-nasal.pdf.
17. Han, L. L., L. K. McDougal, R. J. Gorwitz, K. H. Mayer, J. B. Patel, J. M. Sennott, and J. L. Fontana. 2007. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsedfield type USA300 isolates collected at a Boston ambulatory health center. J. Clin. Microbiol. 45:1350-1352.
18. Herold, B. C., L. C. Immergluck, M. C. Maranan, D. S. Lauderdale, R. E. Gaskin, S. Boyle-Vavra, C. D. Leitch, and R. S. Daum. 1998. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593-598.
19. Ito, T., Y. Katayama, K. Asada, N. Mori, K. Tsutsumimoto, C. Tiensasitorn, and K. Hiramatsu. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1323-1336.
20. Jones, J. C., T. J. Rogers, P. Brookmeyer, W. M. Dunne, Jr., G. A. Storch, C. M. Coopersmith, V. J. Fraser, and D. K. Warren. 2007. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin. Infect. Dis. 45:541-547.
21. Jones, P. G., T. Sura, M. Harris, and A. Strother. 2003. Mupirocin resistance in clinical isolates of Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 24:300-301.
22. Klevens, R. M., M. A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771.
23. Koreen, L., S. V. Ramaswamy, E. A. Graviss, S. Naidich, J. M. Musser, and B. N. Kreiswirth. 2004. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J. Clin. Microbiol. 42:792-799.
24. LaPlante, K. L. 2007. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 57:413-418.
25. Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M. O. Peter, V. Gauduchon, F. Vandenesch, and J. Etienne. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132.
26. McDougal, L. K., G. E. Fosheim, A. Nicholson, S. N. Bulens, B. M. Limbago, J. E. Shearer, A. O. Summers, and J. B. Patel. 2010. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob. Agents Chemother. 54:3804-3811.
27. Mongkolrattanothai, K., P. Mankin, V. Raju, and B. Gray. 2008. Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates. Infect. Control Hosp. Epidemiol. 29:993-994.
28. O'Shea, S., L. Cotter, S. Creagh, S. Lydon, and B. Lucey. 2009. Mupirocin resistance among staphylococci: trends in the southern region of Ireland. J. Antimicrob. Chemother. 64:649-650.
29. Patel, J. B., R. J. Gorwitz, and J. A. Jernigan. 2009. Mupirocin resistance. Clin. Infect. Dis. 49:935-941.
30. Paterson, D. L., J. D. Rihs, C. Squier, T. Gayowski, A. Sagnimeni, and N. Singh. 2003. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation 75:194-198.
31. Perl, T. M., J. J. Cullen, R. P. Wenzel, M. B. Zimmerman, M. A. Pfaller, D. Sheppard, J. Twombley, P. P. French, and L. A. Herwaldt. 2002. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med. 346:1871-1877.
32. Ridenour, G., R. Lampen, J. Federspiel, S. Kritchevsky, E. Wong, and M. Climo. 2007. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect. Control Hosp. Epidemiol. 28:1155-1161.
33. Rotger, M., A. Trampuz, K. E. Piper, J. M. Steckelberg, and R. Patel. 2005. Phenotypic and genotypic mupirocin resistance among staphylococci causing prosthetic joint infection. J. Clin. Microbiol. 43:4266-4268.
34. Simor, A. E., T. L. Stuart, L. Louie, C. Watt, M. Ofner-Agostini, D. Gravel, M. Mulvey, M. Loeb, A. McGeer, E. Bryce, and A. Matlow. 2007. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob. Agents Chemother. 51:3880-3886.
35. Udo, E. E., L. E. Jacob, and B. Mathew. 2001. Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance. J. Med. Microbiol. 50:909-915.
36. Vasquez, J. E., E. S. Walker, B. W. Franzus, B. K. Overbay, D. R. Reagan, and F. A. Sarubbi. 2000. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect. Control Hosp. Epidemiol. 21:459-464.
37. Wikler, M. A. 2008. Performance standards for antimicrobial susceptibility testing: 18th informational supplement, vol. 28. Clinical and Laboratory Standards Institute, Wayne, PA.